IBANDRONÁT MYLAN 150 MG TBL FLM 3
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 218,75 Kč. Maximální cena: 681,52 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Monohydrát natrium-ibandronátu (160,84 mg), kyselina ibandronová (150 mg), monohydrát laktosy, povidon k 29/32, mikrokrystalická celulosa, krospovidon, koloidní bezvodý oxid křemičitý, magnesium-stearát, potahová sousta… |
| Dostupnost / výpadek | Výpadek The latest report from the manufacturer is from 26. 11. 2024. Výroba byla přerušena od 26. 1. 2025. The stated reason was: Výrobní důvody. Resumption of supply is expected 31. 10. 2026Výrobce jako potenciální náhradu uvádí léky s… |
| Kód SÚKL | 0231055 |
What is the maximum co-payment for IBANDRONÁT MYLAN?
If the insurance company contributes, the maximum co-payment is 218,75 Kč. The maximum pharmacy price is 681,52 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does IBANDRONÁT MYLAN have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
462,77 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe IBANDRONÁT MYLAN?
Prescription is not conditional on a medical specialization.
What is the composition of IBANDRONÁT MYLAN?
Monohydrát natrium-ibandronátu (160,84 mg), kyselina ibandronová (150 mg), monohydrát laktosy, povidon k 29/32, mikrokrystalická celulosa, krospovidon, koloidní bezvodý oxid křemičitý, magnesium-stearát, potahová soustava opadry 20g18312 bílá, šelak, černý oxid železitý, propylenglykol. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found
Which medicines are similar to IBANDRONÁT MYLAN?
The medicine belongs to ATC group M05BA06 – Kyselina ibandronová. Medicines with the same active substance can be found here.
Who manufactures IBANDRONÁT MYLAN?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 26. 11. 2024. Production was interrupted as of 26. 1. 2025. The stated reason was: Výrobní důvody.
Resumption of supply is expected 31. 10. 2026
The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for IBANDRONÁT MYLAN?
The medicine has code 0231055. Code details can be found here.
How many packs of IBANDRONÁT MYLAN were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of IBANDRONÁT MYLAN were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026